Thursday, July 7, 2022

ABATTIS BIOCEUTICA COM NPV (OTCMKTS:ATTBF) Finds Renewed Momentum on Corporate Update

ABATTIS BIOCEUTICA COM NPV (OTCMKTS:ATTBF) has been one of the more interesting stories on the OTC over the course of the past 12 months. ATTBF based last summer and then hit its stride around about September 2016. Since then, we have seen as much as 1,300% on the upside, and have held onto the vast majority of those gains. This week, ATTBF has been back on a strong tear, helped at least in part by the company’s update regarding its subsidiaries Northern Vine Canada Inc. and Vergence Naturals Ltd.
“We are very pleased with the continued progress being made to strengthen to the sales, marketing and distribution arm of Abattis and Northern Vine,” said Rob Abenante, President and CEO of Abattis. “We believe that the major value to be derived from the legal cannabinoid space will come from all downstream products and services derived from the cannabis plant.  Vergence will be a direct gateway to sell products formulated at our labs in Northern Vine as well as others products which we are able to infuse with customized cannabinoid formulas.  Abattis is equipped to service both of these rapidly evolving market’s and be fully prepared to be a market leader when recreational laws are passed.”
ABATTIS BIOCEUTICA COM NPV (OTCMKTS:ATTBF) casts itself as a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal marijuana markets in North America.
In essence, ATTBF develops, licenses, and markets health products, medicines, extractions, and ingredients for the biologics, nutraceutical, bioceutical, and cosmetic markets in Canada. It is also involved in the possession of cannabis and related active ingredients, as well as the production of extracts; and bioceutical marketing services in the area of health products.
ATTBF was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corp. in September 2012. Abattis Bioceuticals Corp. was incorporated 1997 and is headquartered in Langley, Canada.
According to company materials, “Abattis is a life sciences and biotechnology company which aggregates, integrates, and invests in cannabis technologies and biotechnology services for the legal cannabis industry developing in Canada. The Company has successfully developed and licensed natural health products, medicines, extractions, and ingredients for the biologics, nutraceutical, bioceutical, and cosmetic markets. The Company is also seeking to acquire exclusive intellectual property rights to agricultural technologies to be employed in extraction and processing of botanical ingredients and compounds. The Company follows strict standard operating protocols, and adheres to the applicable laws of Canada and foreign jurisdictions.”
Find out when $ATTBF reaches critical levels. Subscribe to Right Now by entering your Email in the box below.

As noted above, shares have been strong over the past year, and just sported some renewed momentum this week in response to the company’s update on recent operational moves. One of the key elements in the update was its announcement of the official launch of the Vergence retail website, According to the release, the website is designed to streamline availability of the Vergence’s product lines, both developed in-house by Northern Vine and Abattis, as well as third-party products with which Vergence has distribution agreements. is a full-suite natural health products online store, through which all of Vergence’s products will eventually be featured and for sale.
“We’re very excited to launch, which should deliver not only sales revenue, but also important data on customer metrics for our carried lines,” said Mark Mansfield, VP of Sales at Vergence. “We see this sales portal as our Amazon, driving our goal is to be the go-to online retail location for natural health products. We look forward to the potential of incorporating Northern Vine’s CBD-infusion capabilities with not only the products we develop in-house, but with those we’ve signed distribution and marketing agreements with.”
Now commanding a market cap of $1.80M, ATTBF has a chunk ($867K) of cash on the books, which is balanced by virtually no total current liabilities. The company is pre-revenue at this point. As more color becomes clear on the name, we will review the situation and update our take. Sign-up for continuing coverage on shares of $ATTBF stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in $ATTBF, either long or short, and we have not been compensated for this article.

Related Articles


Please enter your comment!
Please enter your name here

Stay Connected


Latest Articles